Unit of Sale | Concentration | Each |
NDC 0409-7132-66 Case of 50 | 0.45% | NDC 0409-7132-68 50 mL bags |
NDC 0409-7132-67 Case of 50 | 0.45% | NDC 0409-7132-69 100 mL bags |
NDC 0409-7132-02 Case of 24 | 0.45% | NDC 0409-7132-04 250 mL bags |
NDC 0409-7101-66 Case of 50 | 0.9% | NDC 0409-7101-68 50 mL bags |
NDC 0409-7101-67 Case of 50 | 0.9% | NDC 0409-7101-69 100 mL bags |
NDC 0409-7101-02 Case of 24 | 0.9% | NDC 0409-7101-04 250 mL bags |
Store at 20 to 25°C (68 to 77°F). [See USP Controlled Room Temperature.] Protect from freezing.
INSTRUCTIONS FOR USE WITH ADD-VANTAGE VIAL
These instructions for use should be made available to the individuals who perform the reconstitution steps.
To Open:
Peel overwrap at corner and remove solution container. Use unit within 30 days of opening overwrap, as long as the use date does not exceed the printed expiration date. Some opacity of the plastic due to moisture absorption during the sterilization process may be observed. This is normal and does not affect the solution quality or safety. The opacity will diminish gradually.
To Assemble Vial and Flexible Diluent Container:
(Use Aseptic Technique)
Fig. 1 Fig. 2
Fig. 3 Fig. 4
To Reconstitute the Drug:
If the rubber stopper is not removed from the vial and medication is not released on the first attempt, the inner cap may be manipulated back into the rubber stopper without removing the drug vial from the diluent container. Repeat steps 3 through 5.
Fig. 5 Fig. 6 Fig. 7
Preparation for Administration:
(Use Aseptic Technique)
WARNING: Do not use flexible container in series connections.
INSTRUCTIONS FOR USE WITH ADD-VANTAGE ADDAPTOR™
The instructions for use provided with the ADD-Vantage ADDAPTOR™ should be made available to the individuals who perform the reconstitution steps.
Distributed by Hospira, Inc., Lake Forest, IL 60045 USA
LAB-1103-2.0
Revised: 11/2018
Unit of Sale | Concentration | Each |
NDC 0409-7132-66 Case of 50 | 0.45% | NDC 0409-7132-68 50 mL bags |
NDC 0409-7132-67 Case of 50 | 0.45% | NDC 0409-7132-69 100 mL bags |
NDC 0409-7132-02 Case of 24 | 0.45% | NDC 0409-7132-04 250 mL bags |
NDC 0409-7101-66 Case of 50 | 0.9% | NDC 0409-7101-68 50 mL bags |
NDC 0409-7101-67 Case of 50 | 0.9% | NDC 0409-7101-69 100 mL bags |
NDC 0409-7101-02 Case of 24 | 0.9% | NDC 0409-7101-04 250 mL bags |
Store at 20 to 25°C (68 to 77°F). [See USP Controlled Room Temperature.] Protect from freezing.
INSTRUCTIONS FOR USE WITH ADD-VANTAGE VIAL
These instructions for use should be made available to the individuals who perform the reconstitution steps.
To Open:
Peel overwrap at corner and remove solution container. Use unit within 30 days of opening overwrap, as long as the use date does not exceed the printed expiration date. Some opacity of the plastic due to moisture absorption during the sterilization process may be observed. This is normal and does not affect the solution quality or safety. The opacity will diminish gradually.
To Assemble Vial and Flexible Diluent Container:
(Use Aseptic Technique)
Fig. 1 Fig. 2
Fig. 3 Fig. 4
To Reconstitute the Drug:
If the rubber stopper is not removed from the vial and medication is not released on the first attempt, the inner cap may be manipulated back into the rubber stopper without removing the drug vial from the diluent container. Repeat steps 3 through 5.
Fig. 5 Fig. 6 Fig. 7
Preparation for Administration:
(Use Aseptic Technique)
WARNING: Do not use flexible container in series connections.
INSTRUCTIONS FOR USE WITH ADD-VANTAGE ADDAPTOR™
The instructions for use provided with the ADD-Vantage ADDAPTOR™ should be made available to the individuals who perform the reconstitution steps.
Distributed by Hospira, Inc., Lake Forest, IL 60045 USA
LAB-1103-2.0
Revised: 11/2018
Chat online with Pfizer Medical Information regarding your inquiry on a Pfizer medicine.
*Speak with a Pfizer Medical Information Professional regarding your medical inquiry. Available 9AM-5PM ET Monday to Friday; excluding holidays.
Submit a medical question for Pfizer prescription products.
Pfizer Safety
To report an adverse event related to the Pfizer-BioNTech COVID-19 Vaccine, and you are not part of a clinical trial* for this product, click the link below to submit your information:
Pfizer Safety Reporting Site*If you are involved in a clinical trial for this product, adverse events should be reported to your coordinating study site.
If you cannot use the above website, or would like to report an adverse event related to a different Pfizer product, please call Pfizer Safety at (800) 438-1985.
FDA Medwatch
You may also contact the U.S. Food and Drug Administration (FDA) directly to report adverse events or product quality concerns either online at www.fda.gov/medwatch or call (800) 822-7967.